Redington, Inc. http://www.redingtoninc.com Redington Inc. - Financial Communications/Investor Relations Tue, 21 May 2013 19:23:45 +0000 en-US hourly 1 http://wordpress.org/?v=3.5.1 Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference http://www.redingtoninc.com/archives/1038 http://www.redingtoninc.com/archives/1038#comments Tue, 21 May 2013 19:23:45 +0000 admin http://www.redingtoninc.com/?p=1038 Continue reading →]]> http://www.redingtoninc.com/archives/1038/feed 0 Life Science Newsletter – 5/14/13/Redington http://www.redingtoninc.com/archives/1036 http://www.redingtoninc.com/archives/1036#comments Mon, 20 May 2013 09:44:14 +0000 admin http://www.redingtoninc.com/?p=1036 Continue reading →]]> http://www.redingtoninc.com/archives/1036/feed 0 Life Science Newsletter – 5/14/13 http://www.redingtoninc.com/archives/1034 http://www.redingtoninc.com/archives/1034#comments Tue, 14 May 2013 19:03:31 +0000 admin http://www.redingtoninc.com/?p=1034 Continue reading →]]> http://www.redingtoninc.com/archives/1034/feed 0 Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2013 Financial Results http://www.redingtoninc.com/archives/1032 http://www.redingtoninc.com/archives/1032#comments Tue, 07 May 2013 13:47:31 +0000 admin http://www.redingtoninc.com/?p=1032 Continue reading →]]> http://www.redingtoninc.com/archives/1032/feed 0 InspireMD Closes $25 Million Underwritten Public Offering http://www.redingtoninc.com/archives/1029 http://www.redingtoninc.com/archives/1029#comments Tue, 16 Apr 2013 16:27:00 +0000 admin http://www.redingtoninc.com/?p=1029 Continue reading →]]> http://www.redingtoninc.com/archives/1029/feed 0 Synthetic Biologics Reports Year End 2012 Financial Results http://www.redingtoninc.com/archives/1026 http://www.redingtoninc.com/archives/1026#comments Tue, 16 Apr 2013 13:55:37 +0000 admin http://www.redingtoninc.com/?p=1026 Continue reading →]]> http://www.redingtoninc.com/archives/1026/feed 0 22nd Century Group Announces U.S. Patent Issues for MPO Nicotine Biosynthesis Gene http://www.redingtoninc.com/archives/1021 http://www.redingtoninc.com/archives/1021#comments Wed, 03 Apr 2013 14:43:28 +0000 admin http://www.redingtoninc.com/?p=1021 Continue reading →]]> http://www.redingtoninc.com/archives/1021/feed 0 DARA BioSciences Enters Into Distribution Agreement for Gelclair(R) and Soltamox(R) With Prime Therapeutics Specialty Pharmacy http://www.redingtoninc.com/archives/1019 http://www.redingtoninc.com/archives/1019#comments Wed, 03 Apr 2013 14:42:09 +0000 admin http://www.redingtoninc.com/?p=1019 Continue reading →]]> http://www.redingtoninc.com/archives/1019/feed 0 Fibrocell Science Reports 2012 Results http://www.redingtoninc.com/archives/1015 http://www.redingtoninc.com/archives/1015#comments Tue, 02 Apr 2013 14:09:52 +0000 admin http://www.redingtoninc.com/?p=1015 Continue reading →]]> http://www.redingtoninc.com/archives/1015/feed 0 DARA Reports Year-End 2012 Financial Results http://www.redingtoninc.com/archives/1017 http://www.redingtoninc.com/archives/1017#comments Mon, 01 Apr 2013 14:10:27 +0000 admin http://www.redingtoninc.com/?p=1017 Continue reading →]]> http://www.redingtoninc.com/archives/1017/feed 0 Life Science Newsletter – 3/26/13 http://www.redingtoninc.com/archives/1009 http://www.redingtoninc.com/archives/1009#comments Wed, 27 Mar 2013 15:17:23 +0000 admin http://www.redingtoninc.com/?p=1009 Continue reading →]]> http://www.redingtoninc.com/archives/1009/feed 0 Synthetic Biologics to Present at the 25th Annual ROTH Conference http://www.redingtoninc.com/archives/1001 http://www.redingtoninc.com/archives/1001#comments Tue, 12 Mar 2013 14:29:57 +0000 admin http://www.redingtoninc.com/?p=1001 Continue reading →]]> http://www.redingtoninc.com/archives/1001/feed 0 Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2012 Financial Results http://www.redingtoninc.com/archives/998 http://www.redingtoninc.com/archives/998#comments Tue, 12 Mar 2013 14:28:22 +0000 admin http://www.redingtoninc.com/?p=998 Continue reading →]]> http://www.redingtoninc.com/archives/998/feed 0 Ventrus Biosciences Announces Poster Presentation on the Quality of Compounded Topical Diltiazem Hydrochloride Formulations for Anal Fissure at the American Pharmacists Association Meeting http://www.redingtoninc.com/archives/992 http://www.redingtoninc.com/archives/992#comments Wed, 06 Mar 2013 15:40:49 +0000 admin http://www.redingtoninc.com/?p=992 Continue reading →]]> http://www.redingtoninc.com/archives/992/feed 0 DARA BioSciences Appoints Haywood Cochrane Jr. as Chairman of the Board of Directors and Names Paul Richardson as a New Board Member http://www.redingtoninc.com/archives/989 http://www.redingtoninc.com/archives/989#comments Fri, 01 Mar 2013 15:33:54 +0000 admin http://www.redingtoninc.com/?p=989 Continue reading →]]> http://www.redingtoninc.com/archives/989/feed 0 Coronado Biosciences to Present at the Cowen and Co. 33rd Annual Health Care Conference http://www.redingtoninc.com/archives/984 http://www.redingtoninc.com/archives/984#comments Wed, 27 Feb 2013 14:56:51 +0000 admin http://www.redingtoninc.com/?p=984 Continue reading →]]> http://www.redingtoninc.com/archives/984/feed 0 Dynavax to Present at the Cowen and Company 33rd Annual Healthcare Conference http://www.redingtoninc.com/archives/982 http://www.redingtoninc.com/archives/982#comments Tue, 26 Feb 2013 14:43:44 +0000 admin http://www.redingtoninc.com/?p=982 Continue reading →]]> http://www.redingtoninc.com/archives/982/feed 0 Threshold Pharmaceuticals Announces Presentation and Webcast at Cowen and Company’s 33rd Annual Health Care Conference http://www.redingtoninc.com/archives/979 http://www.redingtoninc.com/archives/979#comments Tue, 26 Feb 2013 14:41:01 +0000 admin http://www.redingtoninc.com/?p=979 Continue reading →]]> http://www.redingtoninc.com/archives/979/feed 0 SANUWAVE Health Announces the Appointment of CEO and Closing of its $2.0 Million Bridge Financing http://www.redingtoninc.com/archives/977 http://www.redingtoninc.com/archives/977#comments Tue, 26 Feb 2013 14:38:47 +0000 admin http://www.redingtoninc.com/?p=977 Continue reading →]]> http://www.redingtoninc.com/archives/977/feed 0 Infectious Disease Specialist, Brad Spellberg, M.D., Joins Synthetic Biologics’ Scientific Advisory Board http://www.redingtoninc.com/archives/974 http://www.redingtoninc.com/archives/974#comments Tue, 26 Feb 2013 14:35:52 +0000 admin http://www.redingtoninc.com/?p=974 Continue reading →]]> http://www.redingtoninc.com/archives/974/feed 0